Renewable Standard Reference Material for the Detection of TP53 Mutations

Molecular Diagnosis

Volumn 7, Issue 2, 2003, Pages 85-97

  O'Connell, Catherine D ^a   Tully, Lois A ^a   Devaney, Joseph M ^b   Marino, Michael A ^b   Jakupciak, John P ^a   Atha, Donald H ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b TRANSGENOMIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PLASMID VECTOR; PRIMER DNA; PROTEIN P53;

ACCURACY; AMPLICON; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; CAPILLARY ELECTROPHORESIS; CLONE; CONTROLLED STUDY; DATA ANALYSIS; DENATURING GRADIENT GEL ELECTROPHORESIS; DISEASE ASSOCIATION; DNA DENATURATION; DNA SEQUENCE; DNA STRAND; EXON; GENE MUTATION; GENE TECHNOLOGY; GENETICS; HETERODUPLEX ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LABORATORY; MEASUREMENT; MOLECULAR CLONING; MUTATION; NEOPLASM; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; REFERENCE VALUE; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SITE DIRECTED MUTAGENESIS; STANDARD; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS; WILD TYPE;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; ELECTROPHORESIS, CAPILLARY; EXONS; GENES, P53; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTATION; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REFERENCE STANDARDS;

EID: 0242523684     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.2165/00066982-200307020-00002     Document Type: Article

References (35)

1. Eng C, Brody LC, Wagner TM, et al. Steering Committee of the Breast Cancer Information Core (BIC) Consortium. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. J Med Genet 2001; 38: 824-33
2. Kristensen VN, Kelefiotis D, Kristensen T, et al. High-throughput methods for detection of genetic variation. Biotechniques 2001; 30: 318-32
3. Ellis LA, Taylor CF, Taylor GR. A comparison of fluorescent SSCP and denaturing HPLC for high throughput mutation scanning. Hum Mutat 2000; 15: 556-64
4. Cotton RGH. Mutation detection novel technologies, developments and applications for analysis of the humand genome. Hum Mutat 2002; 19: 313-4
5. Cotton RGH. Slowly but surely towards better scanning for mutations. Trends Genet 1997; 13: 43-5
6. Liu Q, Feng J, Buzin C, et al. Detection of virtually all mutations-SSCP (DOVAM-S): a rapid method for mutation scanning with virtually 100% sensitivity. Biotechniques 1999; 26: 932-42
7. O'Connell CD, Atha DH, Oldenburg MC, et al. Detection of p53 gene mutations: analysis by single strand conformation polymorphism and cleavase fragment length polymorphism. Electrophoresis 1999; 20: 1211-23
8. O'Connel CD, Atha DH, Jakupciak JP, et al. Standardization of PCR Amplification for Fragile X Trinucleotide Repeat Measurements. Clin Genet 2002; 61: 13-20
9. Hollstein M, Sidransky D, Vogelstein B, et al. P53 mutations in human cancer. Science 1991; 253: 49-53
10. Vogelstein B, Kinzer K. p53 function and dysfunction. Cell 1992; 70: 523-6
11. Somlo G, Simpson JF, Frankel P, et al. Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancer. Br J Cancer 2002; 87: 281-8
12. Liu MC, Gelmann EP. p53 gene mutations: case study of a clinical marker for solid tumors. Semin Oncol 2002; 29: 246-57
13. Hollstein M, Rice C, Greenblatt MS, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucl Acids Res 1994: 22: 3551-5
14. Cariello NF, Cui L, Beroud C, et al. Database and software for the analysis of mutations in the human p53 gene. Cancer Res 1994; 54: 4454-60
15. Geisler S, Lonning PE, Aas T, et al. Influence of TP53 gene alterations and c-erb B-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer. Cancer Res 2001; 61: 2505-12
16. Mirza AN, Mirza NQ, Vlastos G, et al. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002; 235: 10-26
17. Genetests laboratory directory [online]. Available from URL: http://www.genetests.org [Accessed 2003 Oct 1]
18. Barker PE, Watson MS, Ticehurst JR, et al. NIST physical standards for DNA-based medical testing. J Clin Lab Anal 2002; 16: 5-10
19. Atha DH, Wenz H-M, Morehead H, et al. Detection of p53 point mutations by single strand conformation polymorphism: analysis by capillary electrophoresis. Electrophoresis 1998; 19: 172-9
20. Orita M, Iwahana H, Kanazawa H, et al. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1989; 86: 2766-70
21. Gelfi C, Righetti SC, Zunino F, et al. Detection of p53 point mutations by double-gradient, denaturing gradient gel electrophoresis. Electrophoresis 1997; 18: 2921-7
22. O'Donovan MC, Oefner PJ, Roberts SC, et al. Blind analysis of denaturing high performance liquid chromatography as a tool for mutation detection. Genomics 1998; 52: 44-9
23. Oefner PJ, Underhill PA. DNA mutation detection using denaturing high-performance liquid chromatography (DHPLC). In: Dracopoli NC, Haines JL, Korff BR, et al., editor. Current protocols in human genetics. Suppl 19. New York: John Wiley and Sons Inc., 1998; 7.10.1-7.10.12
24. Holinski-Feder E, Muller-Koch Y, Friedl W, et al. DHPLC mutation analysis of the hereditary non-polypoisis colon cancer (HNPCC) genes hMLH1 and hMSH2. J Biochem Biophys Methods 2001; 47: 21-32
25. Spiegelman JI, Mindrinos MN, Oefner PJ. High-accuracy DNA sequence variation screening by DHPLC. Biotechniques 2001; 29: 1084-92
26. Keller G, Hartmann A, Mueller J, et al. Denaturing high pressure chromatography (DHPLC) for the analysis of somatic p53 mutations. Lab Invest 2001; 81: 1735-7
27. International Agency for Research in Cancer (IARC) TP53 mutation database [online]. Available from URL: http://www.iarc.fr/p53/ [Accessed 2003 Sep 4]
28. Wenz H-M, Ramachandra S, O'Connell CD, et al. Identification of known p53 point mutations by capillary electrophoresis using unique mobility profiles in a blinded study. Mutat Res 1998; 382: 121-32
29. Greiner TC, Moynihan MJ, Chan WC, et al. p53 mutation in mantle cell lymphome are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302-10
30. Gulberg P, Nedergaard T, Nielson HG, et al. Single step DGGE-based mutation scanning of the p53 gene: application to genetic diagnosis of colorectal cancer. Hum Mutat 1997; 9: 348-55
31. O'Connell CD, Tian J, Juhasz A, et al. Development of standard reference materials for diagnosis of p53 mutations: analysis by slab gel single strand conformation polymorphism. Electrophoresis 1998; 19: 164-71
32. Fodde R, Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 1994; 3: 83-94
33. Anderson TI, Borresen DAL. Alterations of the TP53 gene as a potential prognostic marker in breast carcinomas: advantages of using constant denaturant gel electrophoresis in mutation detection. Diagn Mol Pathol 1995; 4: 203-11
34. Standards and guidelines for clinical genetics laboratories. 2nd ed. Bethesda (MD): American College of Medical Genetics, 1999
35. Ahrendt SA, Halachmi S, Chow JT, et al. Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array. Proc Natl Acad Sci U S A 1999; 96: 7382-7